Arkolith/Insider Trading/CLTX/Form 4

Mintz Hal

10% OwnerCelsus Therapeutics Plc. (CLTX) · full profile →Form 4 · filed Apr 11, 2014
Net Buying
Open-Market Buys
$14K
Open-Market Sells
$0
Net Open-Market Flow
$14K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 11, 2014Buy(P)100$5.15$515758K
Apr 10, 2014Buy(P)1K$5.25$7K758K
Apr 9, 2014Buy(P)1K$5.51$6K756K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001535610-14-000055) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Celsus Therapeutics Plc.

Build

Ask your agent about CLTX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001535610-14-000055"
Ask your agent
Use Arkolith to summarize insider buying and selling at Celsus Therapeutics Plc.
over the last 90 days and cite the filings.